Modified dendritic cells

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) C12N 15/11 (2006.01) C12N 15/74 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2505403

Infection of a dendritic cell with a lentivirus impairs the dendritic cell's ability to act as an antigen presenting cell that polarizes a naïve T cell to develop along the Th1 pathway. This impairment is restored by infecting dendritic cells with lentiviruses containing vectors encoding IL-7, IL-12, and siRNA targeting IL-10 RNA.

L'infection d'une cellule dendritique avec un lentivirus altère l'aptitude de la cellule dendritique à agir comme une cellule présentant un antigène qui polarise un lymphocyte T naïf pour qu'il se développe le long du chemin du Th1. On remédie à cette altération en infectant les cellules dendritiques avec des lentivirus contenant des vecteurs codant l'IL-7, l'IL-12, et l'ARNsi ciblant l'ARN à IL-10.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified dendritic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified dendritic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified dendritic cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1932511

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.